Equillium (EQ) analyst forecast and price target
Analyst forecast
Consensus of 10 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Piper Sandler | Initiated Coverage | Overweight | $20.00 | Jul 13, 2026 |
| Roth Capital | Maintained | Buy | $12.00 | Jun 2, 2026 |
| Roth Capital | Maintained | Buy | $12.00 | May 28, 2026 |
| Leerink Partners | Upgraded | Market Perform → Outperform | $6.00 from $1.00 | May 28, 2026 |
| Roth Capital | Maintained | Buy | $12.00 | Apr 17, 2026 |
| B. Riley Securities | Initiated Coverage | Buy | $6.00 | Apr 16, 2026 |
| Raymond James | Initiated Coverage | Strong Buy | $6.00 | Apr 14, 2026 |
| Roth Capital | Initiated Coverage | Buy | $12.00 | Mar 13, 2026 |
| Leerink Partners | Downgraded | Outperform → Market Perform | $1.00 from $3.00 | Mar 28, 2025 |
| Jones Trading | Downgraded | Buy → Hold | — | Nov 1, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Aug 19, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | Jun 5, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 | May 17, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $5.00 from $4.00 | Apr 2, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 from $4.50 | Dec 26, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $4.50 from $5.50 | Nov 13, 2023 |
| Cantor Fitzgerald | Maintained | Overweight | $2.80 | Aug 14, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $5.50 | Aug 14, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $5.50 | May 15, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $5.50 from $20.00 | May 1, 2023 |
Frequently asked questions
Is EQ a buy, sell, or hold?
Analysts covering Equillium currently average a Buy rating: 10 buy, 0 hold and 0 sell, from 10 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on EQ?
On Jul 13, 2026, Piper Sandler initiated coverage of Equillium at Overweight with a price target of $20.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.